ConductScience.org, home

Paper8137296

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Gillett C and 7 others. Cancer Res, 1994. Cited by 650 papers, by iCite.

Cite this record

ConductScience Library. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Papers, record 8137296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8137296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
PubMed
Journal
Cancer Res
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
650
iCite
Relative citation ratio, by iCite
13.6
iCite
Revised in PubMed
2024-01-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gillett CC
2Fantl VV
3Smith RR
4Fisher CC
5Bartek JJ
6Dickson CC
7Barnes DD
8Peters GG

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Chromosomes, Human, Pair 11Major topic
CyclinsMajor topic
Gene AmplificationMajor topic
Oncogene ProteinsMajor topic
Alleles
Antibodies, Monoclonal
Chromosome Mapping
Cyclin D1
DNA, Neoplasm
Female
Gene Expression
Humans
Immunohistochemistry
Prognosis
RNA, Neoplasm
Transcription, Genetic
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by236

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 650 citations.

PMIDTitleJournalYearIn PapersSource
42629473Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network.EMBO Mol Med2026https://conductscience.org/library/papers/42629473PubMed
42079002γ-Tocotrienol inhibits HeLa cell proliferation likely via modulation of the PI3K/AKT/mTOR signaling pathway.Front Nutr2026https://conductscience.org/library/papers/42079002PubMed
41758262Altered expression and mutations in cell cycle genes CCND1, CDK4, CDKN2B and TP53 are associated with Pakistani breast cancer patients.Mol Biol Rep2026https://conductscience.org/library/papers/41758262PubMed
41710088Charting the multilevel molecular response to palbociclib in ER-positive breast cancer.NAR Cancer2026https://conductscience.org/library/papers/41710088PubMed
41646949Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice?ESMO Gastrointest Oncol2024https://conductscience.org/library/papers/41646949PubMed
40233410A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40233410PubMed
40034931Expression of Cyclin D1 and Claudin-1 in Invasive Breast Carcinoma and Their Correlation with Clinicopathological Parameters.Iran J Pathol2024https://conductscience.org/library/papers/40034931PubMed
39885369Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer.Nat Cancer2025https://conductscience.org/library/papers/39885369PubMed
39591896BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair.Transl Oncol2025https://conductscience.org/library/papers/39591896PubMed
39412532Intramammary Labeling of Epithelial Cell Division.J Mammary Gland Biol Neoplasia2024https://conductscience.org/library/papers/39412532PubMed
38831405Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.Mol Cancer2024https://conductscience.org/library/papers/38831405PubMed
38685777Envisioning Clinical Management of Breast Cancer: a Comprehensive Review.Curr Drug Discov Technol2025https://conductscience.org/library/papers/38685777PubMed
38082107The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment.Nat Rev Clin Oncol2024https://conductscience.org/library/papers/38082107PubMed
37024471Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation.Cell Death Dis2023https://conductscience.org/library/papers/37024471PubMed
36628275Non-canonical approaches to targeting hypoxic tumors.Am J Cancer Res2022https://conductscience.org/library/papers/36628275PubMed
36243802A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.Oncogene2022https://conductscience.org/library/papers/36243802PubMed
36001804Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth.Mol Cancer Res2022https://conductscience.org/library/papers/36001804PubMed
35942997Immunohistochemical Overexpression of Cyclin D1 in Tunisian Invasive Breast Carcinoma Women.Arch Iran Med2022https://conductscience.org/library/papers/35942997PubMed
35781526Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/35781526PubMed
35595729Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression.Cell Death Dis2022https://conductscience.org/library/papers/35595729PubMed

See all 236 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CCNL281669PubTator's text mininghttps://conductscience.org/library/genes/81669NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8137296

GET https://conductscience.org/api/papers/v1/8137296/cited_by?page=2